Record Adjusted EBITDA Margins
ESAB achieved record adjusted EBITDA margins of 20.4% during the quarter, indicating strong operational performance and resilience.
Strong Performance in EMEA and APAC
EMEA and APAC regions delivered double-digit growth in the Middle East and high single-digit growth in India, contributing to overall sales growth of 11% in these regions.
Successful Acquisitions
The acquisitions of DeltaP, Aktiv, and EWM were completed, enhancing ESAB's product offerings and strategic position in the market.
Raised Full-Year Guidance
Given the strong performance and confidence in the business, ESAB raised its full-year guidance for revenue and adjusted EBITDA.
Expansion of Medical Gas Portfolio
The acquisitions of DeltaP and Aktiv expanded the medical gas portfolio, increasing the total available market by $200 million.